Skip to main content
. 2016 Jul 22;14:189. doi: 10.1186/s12957-016-0946-x

Fig. 6.

Fig. 6

Kaplan-Meier survival plot of 126 colorectal cancers (KRAS wildtype and KRAS mutated) in relation to p62 immunostaining intensity. p62-negative CRC revealed a significantly decreased OS (log-rank test: p = 0.043)